Protonix I.v.
Product manufactured by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.
Indications and Purposes
| 1 Indications And Usage Protonix Is A Proton Pump Inhibitor (Ppi) Indicated In Adults For The Following: Short-Term Treatment (7 To 10 Days) Of Gastroesophageal Reflux Disease (Gerd) Associated With A History Of Erosive Esophagitis (Ee). ( 1.1 ) Pathological Hypersecretion Conditions Including Zollinger-Ellison (Ze) Syndrome. ( 1.2 ) 1.1 Gastroesophageal Reflux Disease Associated With A History Of Erosive Esophagitis Protonix I.v. Is Indicated For Short-Term Treatment (7 To 10 Days) Of Adult Patients With Gastroesophageal Reflux Disease (Gerd) And A History Of Erosive Esophagitis (Ee). Safety And Efficacy Of Protonix I.v. As A Treatment Of Patients With Gerd And A History Of Ee For More Than 10 Days Have Not Been Demonstrated. 1.2 Pathological Hypersecretion Including Zollinger-Ellison Syndrome Protonix I.v. Is Indicated For The Treatment Of Pathological Hypersecretory Conditions Including Zollinger-Ellison (Ze) Syndrome In Adults. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Pantoprazole Sodium |
|
ZINC4099200 |